Author:
Long Matthew E.,Gong Ke-Qin,Eddy William E.,Liles W. Conrad,Manicone Anne M.
Funder
National Heart, Lung, and Blood Institute
Cystic Fibrosis Foundation
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference18 articles.
1. Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015;372:351–62.
2. Caunt CJ, Sale MJ, Smith PD, Cook SJ. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nat Rev Cancer. 2015;15:577–92.
3. Long ME, Eddy WE, Gong KQ, Lovelace-Macon LL, McMahan RS, Charron J, Liles WC, Manicone AM. MEK1/2 inhibition promotes macrophage reparative properties. J Immunol. 2017;198:862–72.
4. Zhang L, Chen Y, Yang X, Yang J, Cao X, Li X, Li L, Miao QR, Hajjar DP, Duan Y, Han J. MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-an anti-atherogenic function of ERK1/2 inhibition. Biochim Biophys Acta. 1861;2016:1180–91.
5. Smith JA, Mayeux PR, Schnellmann RG. Delayed Mitogen-activated protein Kinase/extracellular signal-regulated Kinase inhibition by Trametinib attenuates systemic inflammatory responses and multiple organ injury in Murine sepsis. Crit Care Med. 2016;44:e711–20.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献